ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260635.1	Gefitinib	Bladder urothelial carcinoma	0.026162359	Resistant
ENSG00000260635.1	Gefitinib	Ovarian serous cyStomach adenocarcinomaenocarcinoma	0.032128161	Resistant